HCPLive® peer-to-peer panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's cancer care professionals.
Improving Quality of Life in Atopic Dermatitis With Targeted Therapies
April 14th 2023Experts in dermatology focus on how new and advanced treatments are impacting the quality of life for individuals with atopic dermatitis (AD). They explore how to optimize the patient experience by utilizing these therapies in a strategic matter.
Restoring Skin Pigmentation in Vitiligo With Advanced Treatments
April 12th 2023Experts in dermatology discuss the pathophysiology of vitiligo, current standards of care, and new and emerging therapies. They also explore evidence-based approaches and patient-centered care to manage vitiligo and improve patient outcomes.
Personalizing Treatment Selection in Atopic Dermatitis
December 20th 2022Expert dermatologists discuss 3 patient case scenarios and their approach to finding the best treatment for each patient type. They discuss data, pros and cons of use of various classes of treatments, approaches to monitoring the disease, and changing treatment based on patient and disease characteristics.
Expert Perspectives on Advances in the Management of Major Depressive Disorder
December 16th 2022Experts in psychiatry focus on treatment options for major depressive disorder (MDD). The discussion centers on data with newer mechanisms of action, new and emerging treatment options, and management of MDD in specific patient populations and how new treatments are aiming to fulfill unmet needs in MDD.
Advances in Targeted Therapy Selection in Rheumatoid Arthritis
December 7th 2022Rheumatology specialists discuss challenges in the management of rheumatoid arthritis (RA), and how the trial-and-error approach to treatment selection and continued use of ineffective treatments impacts quality of life in RA. The panel discusses tools available to guide treatment selection and how personalization of care can improve treatment outcomes.
Recent Approvals in Vaccination Against SARS-CoV-2 and the Omicron Subvariants
October 24th 2022Expert health professionals provide key insights on recently approved SARS-CoV-2 booster shots highlighting current recommendations and optimizing patient communication and education on vaccination options.